Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
354.20
+29.60 (9.12%)
At close: Dec 4, 2025

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 95.16 million as of December 5, 2025. Its market cap has increased by 12.27% in one year.

Market Cap
95.16M
Enterprise Value
38.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
354.20

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 95.16M, a decrease of -74.14%. That is a compound annual growth rate of -18.28%.

History

DateMarket Cap% Change
Dec 5, 202595.16M1.55%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 105.66B
Danel (Adir Yeoshua) 2.71B
Kamada 1.33B
BrainsWay 1.08B
Bait Bakfar 1.04B
SofWave Medical 997.78M
Ilex Medical 717.72M
Novolog (Pharm-Up 1966) 644.72M
Market Cap Rankings